RedHill Biopharma (RDHL) Times Interest Earned: 2009-2024
Historic Times Interest Earned for RedHill Biopharma (RDHL) over the last 16 years, with Dec 2024 value amounting to -$7.11.
- RedHill Biopharma's Times Interest Earned rose 377.26% to $27.91 in Q2 2023 from the same period last year, while for Jun 2023 it was -$1.20, marking a year-over-year increase of 87.34%. This contributed to the annual value of -$7.11 for FY2024, which is 640.43% down from last year.
- Latest data reveals that RedHill Biopharma reported Times Interest Earned of -$7.11 as of FY2024, which was down 640.43% from $1.32 recorded in FY2023.
- In the past 5 years, RedHill Biopharma's Times Interest Earned ranged from a high of $4.99 in FY2020 and a low of -$7.11 during FY2024.
- Over the past 3 years, RedHill Biopharma's median Times Interest Earned value was -$1.01 (recorded in 2022), while the average stood at -$2.27.
- In the last 5 years, RedHill Biopharma's Times Interest Earned surged by 230.11% in 2023 and then crashed by 640.43% in 2024.
- RedHill Biopharma's Times Interest Earned (Yearly) stood at $4.99 in 2020, then plummeted by 197.57% to -$4.87 in 2021, then surged by 79.24% to -$1.01 in 2022, then soared by 230.11% to $1.32 in 2023, then slumped by 640.43% to -$7.11 in 2024.